This page shows the latest Intec news and features for those working in and with pharma, biotech and healthcare.
according to Higgins, who also says that “feasibility agreements are key to Intec’s outlook”. ... Ladenburg Thalman has previously estimated that the Novartis deal could be worth $30m to $80m upfront to Intec, with the potential to also generate
Analysts at Ladenburg Thalmann said they were “surprised and disappointed” by the results, and had downgraded Intec’s shares from Buy to Neutral as a result. ... Intec had around $32m in cash at the end of May, down from $39m at the end of 2018.
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
225. Intec Pharma/ Undisclosed Company. R&D collaboration plus option. Accordian Pill (gastro retentive delivery system).
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
Evoke Kyne is an award-winning communications agency that harnesses insight, experience and creativity to advance health and wellbeing around the world. We were founded on the belief that...